Arthritis Research & Therapy

official impact factor 4.36

Download references

Open Access Highly Access

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Thomas Dörner*, Joerg Kaufmann, William A Wegener, Nick Teoh, David M Goldenberg and Gerd R Burmester

Arthritis Research & Therapy 2006, 8:R74 doi:10.1186/ar1942

Include


Format